Your browser doesn't support javascript.
loading
Natural History of Neuronal Ceroid Lipofuscinosis Type 6, Late Infantile Disease.
O'Neal, Matthew; Noher de Halac, Ines; Aylward, Shawn C; Yildiz, Vedat; Zapanta, Bianca; Abreu, Nicolas; de Los Reyes, Emily.
Afiliação
  • O'Neal M; Department of Pediatric Neurology, Nationwide Children's Hospital, Columbus, Ohio.
  • Noher de Halac I; Consultant Professor, National University of Cordoba, Córdoba, Argentina.
  • Aylward SC; Department of Pediatric Neurology, Nationwide Children's Hospital, Columbus, Ohio; The Ohio State University College of Medicine, Columbus, Ohio.
  • Yildiz V; Biostatistics Resource at Nationwide Children's Hospital (BRANCH), Nationwide Children's Hospital, Columbus, Ohio; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, Ohio.
  • Zapanta B; Division of Molecular and Human Genetics, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio.
  • Abreu N; Department of Neurology, NYU Grossman School of Medicine, New York, New York.
  • de Los Reyes E; Department of Pediatric Neurology, Nationwide Children's Hospital, Columbus, Ohio; The Ohio State University College of Medicine, Columbus, Ohio. Electronic address: Emily.delosReyes@nationwidechildrens.org.
Pediatr Neurol ; 154: 51-57, 2024 May.
Article em En | MEDLINE | ID: mdl-38531163
ABSTRACT

BACKGROUND:

Mutations in the CLN6 gene cause late infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disease of childhood onset. Clinically, individuals present with progressive motor and cognitive regression, ataxia, and early death. The aim of this study is to establish natural history data of individuals with classic, late-infantile-onset (age less than five years) CLN6 disease.

METHODS:

We analyzed the natural history of 25 patients with late-infantile-onset CLN6, utilizing the Hamburg motor-language scale to measure disease progression. The key outcomes were CLN6 disease progression, assessed by rate of decline in motor and language clinical domain summary scores (0 to 6 total points); onset and type of first symptom; onset of first seizure; and time from first symptom to complete loss of function.

RESULTS:

Median age of total motor and language onset of decline was 42 months (interquartile range 36 to 48). The estimated rate of decline in total score was at a slope of -1.20 (S.D. 0.30) per year, after the start of decline. Complete loss of both motor and language function was found to be, on average, 88.1 months (S.D. 13.5).

CONCLUSIONS:

To our knowledge, this is the largest international study that monitors the longitudinal natural history and progression of CLN6 disease. These data may serve as a template for future interventional trials targeted to slow the progression of this devastating disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipofuscinoses Ceroides Neuronais Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipofuscinoses Ceroides Neuronais Idioma: En Ano de publicação: 2024 Tipo de documento: Article